This small data-center chipmaker plans to adopt TSMC's 7-nanometer manufacturing technology.
We talk value investing in tech to follow up our P/E episode on growth investing. Analyst John Rotonti explains some key metrics and discusses a few companies he really likes in the tech space.
Both stocks suffered downgrades this morning, but the damage doesn't end there.
Investors were less than impressed with the software king’s latest earnings, and that translates to a great opportunity.
Of course a stock buyback doesn't look good to Wall Street. Their investing time horizon is too different from yours or mine.
Facebook, Alphabet, Allergan, Amazon, and Apple are widely owned by hedge fund managers.
Acadia's newly approved Parkison's disease drug could trigger a buyout. Here's why.
Comments from another company along the OLED technology food chain point to massive demand coming down the pipeline. And that road goes right through Cupertino.
Shares of the OLED specialist have rallied following massive OLED equipment orders for a certain Cupertino-based tech titan.
Achillion Pharmaceuticals, Ophthotech Corp., and Kite Pharmaceuticals shares could move wildly because of upcoming trial data.